Detalhe da pesquisa
1.
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.
J Immunol
; 192(9): 4164-73, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24683185
2.
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.
J Autoimmun
; 40: 96-110, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23026773
3.
Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.
J Chem Technol Biotechnol
; 80(1): 2-12, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973070
4.
MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.
J Immunol
; 180(2): 1249-57, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18178865
5.
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
J Immunol
; 171(4): 1934-40, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12902496